Allergan (AGN) Tops Q3 EPS by 30c

November 4, 2015 7:30 AM EST

Allergan (NYSE: AGN) reported Q3 EPS of $3.48, $0.30 better than the analyst estimate of $3.18. Revenue for the quarter came in at $4.1 billion versus the consensus estimate of $4.03 billion.

For earnings history and earnings-related data on Allergan (AGN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Hot Earnings

Related Entities

Earnings